Paper3301149
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.
Ferner RE and 1 other. Clin Pharmacokinet, 1987. Cited by 79 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Papers, record 3301149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3301149
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypoglycemic Agents | Major topic |
| Administration, Oral | |
| Humans | |
| Kinetics |
Source PubMed
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,046,753 | Effects of tolbutamide on insulin binding to isolated fat cells of the rat. | Biochem Pharmacol | 1982 | https://conductscience.org/library/papers/7046753 | PubMed |
| 2 | 6,376,219 | Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. | Diabetes | 1984 | https://conductscience.org/library/papers/6376219 | PubMed |
| 3 | 6,759,246 | Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. | Diabetes | 1982 | https://conductscience.org/library/papers/6759246 | PubMed |
| 4 | 6,811,355 | Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. | Diabetologia | 1982 | https://conductscience.org/library/papers/6811355 | PubMed |
| 5 | 7,175,719 | Bioavailability of tolazamide from tablets: comparison of in vitro and in vivo results. | J Pharm Sci | 1982 | https://conductscience.org/library/papers/7175719 | PubMed |
| 6 | 3,517,646 | Type II diabetes: insulin versus oral agents. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3517646 | PubMed |
| 7 | 3,923,454 | Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use. | Pharmacotherapy | 1985 | https://conductscience.org/library/papers/3923454 | PubMed |
| 8 | 7,116,738 | Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7116738 | PubMed |
| 9 | 134,717 | Comparative study of the hypoglycaemic and antilipolytic effects of four antidiabetic agents administered i.v. | Arzneimittelforschung | 1976 | https://conductscience.org/library/papers/134717 | PubMed |
| 10 | 6,421,561 | [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)]. | Dtsch Med Wochenschr | 1984 | https://conductscience.org/library/papers/6421561 | PubMed |
| 11 | 690,998 | Metabolic fate of tolazamide in man and in the rat. | J Med Chem | 1978 | https://conductscience.org/library/papers/690998 | PubMed |
| 12 | 4,704,717 | Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect. | Metabolism | 1973 | https://conductscience.org/library/papers/4704717 | PubMed |
| 13 | 913,025 | Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/913025 | PubMed |
| 14 | 14,318,586 | FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS. | Diabetes | 1965 | https://conductscience.org/library/papers/14318586 | PubMed |
| 15 | 4,032,245 | Effect of food and tablet age on relative bioavailability and pharmacodynamics of two tolbutamide products. | J Pharm Sci | 1985 | https://conductscience.org/library/papers/4032245 | PubMed |
| 16 | 3,089,912 | Massive glibenclamide overdose without hypoglycaemia in a man with diabetes after partial pancreatectomy. | Hum Toxicol | 1986 | https://conductscience.org/library/papers/3089912 | PubMed |
| 17 | 389,600 | Glipizide: a review of its pharmacological properties and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/389600 | PubMed |
| 18 | 3,935,463 | Absorption of glibenclamide from different sites of the gastro-intestinal tract. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3935463 | PubMed |
| 19 | 7,028,776 | Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus. | J Clin Endocrinol Metab | 1981 | https://conductscience.org/library/papers/7028776 | PubMed |
| 20 | 569,611 | Pharmacogenetics of tolbutamide metabolism in humans. | Diabetes | 1979 | https://conductscience.org/library/papers/569611 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,551,662 | Treatment of sulfonylurea and insulin overdose. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26551662 | PubMed |
| 23,440,669 | Interactions of rosiglitazone and anti-arrhythmic drugs in animal model. | Ann Med Health Sci Res | 2012 | https://conductscience.org/library/papers/23440669 | PubMed |
| 21,264,118 | Drug-drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats. | J Young Pharm | 2010 | https://conductscience.org/library/papers/21264118 | PubMed |
| 20,437,462 | Contributions of human cytochrome P450 enzymes to glyburide metabolism. | Biopharm Drug Dispos | 2010 | https://conductscience.org/library/papers/20437462 | PubMed |
| 16,372,821 | Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16372821 | PubMed |
| 16,356,235 | Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. | Crit Care | 2005 | https://conductscience.org/library/papers/16356235 | PubMed |
| 9,825,953 | Management of antidiabetic medications in overdose. | Drug Saf | 1998 | https://conductscience.org/library/papers/9825953 | PubMed |
| 8,972,242 | Oral antidiabetic drug use in the elderly. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8972242 | PubMed |
| 8,853,933 | Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8853933 | PubMed |
| 8,739,909 | Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? | Diabetologia | 1996 | https://conductscience.org/library/papers/8739909 | PubMed |
| 8,312,676 | Problems and pitfalls of sulphonylurea therapy in older patients. | Drugs Aging | 1993 | https://conductscience.org/library/papers/8312676 | PubMed |
| 7,988,624 | The effect of hyperglycaemia on the absorption of glibenclamide in patients with non-insulin-dependent diabetes mellitus. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7988624 | PubMed |
| 7,848,543 | Comparative tolerability profiles of oral antidiabetic agents. | Drug Saf | 1994 | https://conductscience.org/library/papers/7848543 | PubMed |
| 7,741,982 | Antihyperglycaemic agents. Drug interactions of clinical importance. | Drug Saf | 1995 | https://conductscience.org/library/papers/7741982 | PubMed |
| 3,129,103 | Sulphonylureas and hypoglycaemia. | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/3129103 | PubMed |
| 2,656,043 | Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2656043 | PubMed |
| 2,651,086 | Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. | Drugs | 1989 | https://conductscience.org/library/papers/2651086 | PubMed |
| 2,271,372 | The effect of cholestyramine and activated charcoal on glipizide absorption. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2271372 | PubMed |
| 2,116,159 | Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2116159 | PubMed |
| 2,109,700 | Possible protein binding displacement interaction between glibenclamide and metolazone. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2109700 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3301149
GET https://conductscience.org/api/papers/v1/3301149/references?page=2